Tumor-adjacent s1-CAFs highly express ACTA2 and TGFB1, thereby promoting ECM remodeling and immune exclusion, while s4-CAFs, which are associated with tertiary lymphoid structures, express high levels of HLA-II molecules and chemokines, supporting anti-tumor immune responses (28). The gene discussed is ACTA2; the disease is neoplasm.